Pharmaceuticals - Paraguay

Paraguay

The Pharmaceuticals market in Paraguay is expected to achieve a revenue of US$235.00m by the year 2024.
among the various markets of the market, Oncology Drugs holds the largest share, with a projected market volume of US$43.35m in the same year.
It is anticipated that the revenue will experience a steady growth with an annual growth rate (CAGR 2024-2028) of 6.24%, resulting in a market volume of US$299.40m by 2028.
When compared to the global market, United States is expected to generate the highest revenue, reaching a staggering US$636.90bn in 2024.
Paraguay's pharmaceutical market is experiencing a surge in demand for generic drugs due to cost-conscious consumers.

Key regions: United States, China, Germany, Japan, Europe

Definition:
The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.

Structure:
The market is subdivided into Oncology Drugs, Anti-Diabetes Drugs, Anti-Rheumatic Drugs, Vaccines, Dermatological Drugs, Antiviral Drugs, Immunosuppressants, Bronchodilator Drugs, Sensory Organ Drugs, Anti-Hypertensive Drugs, Anti-Coagulants, Anti-Fibrinolytic Drugs, Multiple Sclerosis Drugs, Lipid-Lowering Agents and Other Pharmaceuticals. The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs.The Oncology Drugs market covers pharmaceutical products specifically developed for the treatment and management of various cancers. The Anti-Diabetes Drugs market covers medications designed to manage blood glucose levels and improve insulin sensitivity in individuals with diabetes. The market Anti-Rheumatic Drugs includes pharmaceuticals specifically developed to alleviate symptoms, reduce inflammation, and modify the progression of rheumatic diseases. The Dermatological Drugs market covers pharmaceuticals formulated to treat and manage a wide range of skin conditions such as eczema, acne, and rosacea. The Antiviral Drugs market includes medications designed to treat viral infections and reducing the severity and duration of symptoms. The Immunosuppressants market covers pharmaceuticals that suppress the immune system's activity. The Bronchodilator Drugs market covers pharmaceuticals designed to relax and widen the airways in the lungs. The Sensory Organ Drugs market covers pharmaceuticals targeting the treatment of disorders and conditions affecting sensory organs such as the eyes, ears and nose. The Anti-hypertensive Drugs market covers pharmaceuticals designed to lower blood pressure levels. The Anti-Coagulants Drugs market covers pharmaceuticals developed to prevent the formation of blood clots or to dissolve existing clots. The Anti-Fibrinolytics Drugs market covers pharmaceuticals designed to inhibit the breakdown of blood clots. The Multiple Sclerosis Drugs market covers pharmaceuticals aimed at managing and modifying the course of multiple sclerosis. The Lipid-Lowering Agents market covers pharmaceuticals developed to reduce levels of cholesterol and other lipids in the blood. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi.

Market

Region

Region comparison

Currency

Analyst Opinion

The Pharmaceuticals market in Paraguay has been experiencing steady growth in recent years.

Customer preferences: Customers in Paraguay have a strong preference for generic drugs due to their lower cost compared to branded drugs. This trend is driven by the high poverty rate in the country, which limits the purchasing power of many Paraguayans. Additionally, the population tends to favor traditional medicine and natural remedies, which has limited the growth of the pharmaceutical market in the country.

Trends in the market: The Paraguayan pharmaceutical market has been growing steadily due to increased access to healthcare services and a growing population. The market is dominated by generic drugs, which account for the majority of sales. However, there has been a recent trend towards the use of more specialized drugs, particularly in the treatment of chronic diseases such as diabetes and hypertension. This trend is expected to continue as the population ages and the burden of chronic disease increases.

Local special circumstances: One of the unique features of the Paraguayan pharmaceutical market is the prevalence of informal drug sales. Many Paraguayans purchase drugs from street vendors or informal markets, which can pose a significant risk to public health. This is due in part to the lack of regulation and oversight in the market, which has allowed unlicensed vendors to operate freely.

Underlying macroeconomic factors: The Paraguayan economy has been growing steadily in recent years, which has contributed to the growth of the pharmaceutical market. However, the country still faces significant challenges, including high levels of poverty and limited access to healthcare services. These factors have limited the growth of the market and will continue to be a challenge for the industry moving forward. Additionally, the lack of regulation and oversight in the market has made it difficult for pharmaceutical companies to operate in the country, which has limited investment and innovation in the industry.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.